A Prospective Observational Study of Foam Sclerotherapy .
A Prospective Observational Study of Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney and Liver Disease.
Sponsor: Mayo Clinic
This observational or N/A phase trial investigates Autosomal Dominant Polycystic Kidney and Autosomal Dominant Polycystic Liver Disease and is currently actively recruiting participants. Mayo Clinic leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Jan 2025 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Dec 2022 — Dec 2023 [monthly]
Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Recruiting
-
Mar 2022 — Sep 2022 [monthly]
Recruiting
-
Oct 2021 — Mar 2022 [monthly]
Recruiting
-
Feb 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Mar 2020 [monthly]
Recruiting
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .